SE8304144L - Forfarande for forlengning av uppehallstiden for emulsionspartiklar i blodomloppet - Google Patents

Forfarande for forlengning av uppehallstiden for emulsionspartiklar i blodomloppet

Info

Publication number
SE8304144L
SE8304144L SE8304144A SE8304144A SE8304144L SE 8304144 L SE8304144 L SE 8304144L SE 8304144 A SE8304144 A SE 8304144A SE 8304144 A SE8304144 A SE 8304144A SE 8304144 L SE8304144 L SE 8304144L
Authority
SE
Sweden
Prior art keywords
circumstances
duration
blood
procedure
extending
Prior art date
Application number
SE8304144A
Other languages
English (en)
Other versions
SE8304144D0 (sv
Inventor
H A Sloviter
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of SE8304144D0 publication Critical patent/SE8304144D0/sv
Publication of SE8304144L publication Critical patent/SE8304144L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8304144A 1982-07-27 1983-07-26 Forfarande for forlengning av uppehallstiden for emulsionspartiklar i blodomloppet SE8304144L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/402,449 US4397870A (en) 1982-07-27 1982-07-27 Process for prolonging retention of emulsion particles in the bloodstream

Publications (2)

Publication Number Publication Date
SE8304144D0 SE8304144D0 (sv) 1983-07-26
SE8304144L true SE8304144L (sv) 1984-01-28

Family

ID=23591925

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304144A SE8304144L (sv) 1982-07-27 1983-07-26 Forfarande for forlengning av uppehallstiden for emulsionspartiklar i blodomloppet

Country Status (6)

Country Link
US (1) US4397870A (sv)
CA (1) CA1201655A (sv)
DE (1) DE3326900A1 (sv)
FR (1) FR2531857B1 (sv)
GB (1) GB2124079B (sv)
SE (1) SE8304144L (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
GB8407557D0 (en) * 1984-03-23 1984-05-02 Hayward J A Polymeric lipsomes
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US5077036A (en) * 1986-01-14 1991-12-31 Alliance Pharmaceutical Corp. Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
US5080885A (en) * 1986-01-14 1992-01-14 Alliance Pharmaceutical Corp. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
DE3700911C2 (de) * 1986-01-17 2001-05-17 West Pharm Serv Drug Res Ltd System zur Zuführung eines Arzneimittels oder eines Diagnostikums
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
EP0257758B1 (en) * 1986-08-07 1993-03-10 Minnesota Mining And Manufacturing Company Stable biologically active fluorochemical emulsions
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
DE3863908D1 (de) * 1987-11-27 1991-08-29 Akzo Nv Stabilisierung von antikoerpern.
US5061484A (en) * 1988-03-11 1991-10-29 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
WO1991000110A1 (en) * 1989-07-05 1991-01-10 Alliance Pharmaceutical Corp. Fluorocarbon emulsions having saturated phospholipid emulsifiers
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
US5350359A (en) * 1992-07-16 1994-09-27 Temple University Of The Commonwealth System Of Higher Education Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
DE4308312A1 (de) * 1993-03-16 1994-09-22 Fresenius Ag Kardioplegische Emulsion
US6679859B1 (en) 1997-10-24 2004-01-20 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
US8192845B2 (en) * 2005-11-04 2012-06-05 Cargill, Incorported Lecithin-containing starch compositions, preparation thereof and paper products having oil and grease resistance, and/or release properties
US7931778B2 (en) 2005-11-04 2011-04-26 Cargill, Incorporated Lecithin-starches compositions, preparation thereof and paper products having oil and grease resistance, and/or release properties

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH604490A5 (sv) * 1970-09-05 1978-09-15 Green Cross Corp
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
JPS5331209B2 (sv) * 1973-10-05 1978-09-01
FR2249657B1 (sv) * 1973-11-07 1977-04-15 Ugine Kuhlmann
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4186253A (en) * 1978-10-10 1980-01-29 The Green Cross Corporation Perfusate for preserving organ to be transplanted and preserving method
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad

Also Published As

Publication number Publication date
GB2124079A (en) 1984-02-15
GB2124079B (en) 1987-02-04
DE3326900A1 (de) 1984-02-16
CA1201655A (en) 1986-03-11
FR2531857A1 (fr) 1984-02-24
SE8304144D0 (sv) 1983-07-26
GB8318541D0 (en) 1983-08-10
FR2531857B1 (fr) 1986-04-11
US4397870A (en) 1983-08-09

Similar Documents

Publication Publication Date Title
SE8304144D0 (sv) Forfarande for forlengning av uppehallstiden for emulsionspartiklar i blodomloppet
NL187611C (nl) Sterilisatie-hulpstuk, bestemd voor plaatsing op het naaldhoudereinde van een injectiespuit.
NL190397B (nl) Dialysesonde voor toepassing in een biologisch weefsel, zoals hersenweefsel.
DK618088D0 (da) Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof
SE7512883L (sv) Sett att framstella preparat med reglerad frigoring av en aktiv komponent
DE3775449D1 (de) Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung.
GB1359007A (en) Prosthetic device
DK0519926T3 (da) Transdermalt system
ES9400003A1 (es) Procedimiento para la preparacion de substratos con capacidad de absorcion a base de dispersiones de plastico.
DE3481997D1 (de) Verfahren zur herstellung optisch aktiver aryloxypropionsaeuren und deren als herbizide verwendbare derivate.
ATE7228T1 (de) Imidazolinderivat, dessen salze, verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
SE8701479L (sv) Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
DE3381624D1 (de) Mittel zur behandlung von wunden.
OA07539A (fr) Nouveaux dérivés d'acides phényl aliphatiques, leur préparation, leur application comme médicaments, et les compositions les renfermant.
DE3165050D1 (en) Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
NO158984C (no) Anvendelse av (e)-beta-farnesen i vaeskeform eller av en (e)-beta-farnesen-inneholdende vaeske som et kontaktinsekticidmot bladlus.
NL7611449A (nl) Werkwijze voor het bereiden van trichloormethyl- -trifluormethylbenzenen, werkwijze voor het be- reiden van preparaten met insecticide en fungi- cide werking onder toepassing van deze verbin- dingen, alsmede de gevormde preparaten.
ATE37871T1 (de) Substituierte azabicycloalkane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
Diderholm et al. An autoradiographic study of the difference between thymus and lymph node lymphocytes shown by transfusion of labelled cells
DE3669159D1 (de) Triazinderivate, verfahren zur herstellung dieser derivate und herbizide, welche diese derivate als wirksame komponente enthalten.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
SE8503447D0 (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
PT65644B (de) Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide
KR890011887A (ko) 이미다조벤조디아제핀에 의한 공포상태의 예방 및 중지방법

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8304144-2

Effective date: 19900413